Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fatty Acid Supplements Alter Biological Signatures in Children With Autism Spectrum Disorder

NCT03550209 is registered in ClinicalTrials.gov with Sarah Keim as lead sponsor.

NCT NCT03550209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03550209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fatty Acid Supplements Alter Biological Signatures in Children With Autism Spectrum Disorder
Lead sponsor
Sarah Keim
Phase
Phase 2
Overall status
Completed
Start date
June 28, 2018
Completion date
January 10, 2020
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder